These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 36758379)

  • 21. Nucleic Acid Sensing Machinery: Targeting Innate Immune System for Cancer Therapy.
    Iurescia S; Fioretti D; Rinaldi M
    Recent Pat Anticancer Drug Discov; 2018; 13(1):2-17. PubMed ID: 29086701
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbiome and cancer treatment: Are we ready to apply in clinics?
    Chan SL
    Prog Mol Biol Transl Sci; 2020; 171():301-308. PubMed ID: 32475526
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of the microscopic world: Exploring the role and potential of intratumoral microbiota in cancer immunotherapy.
    Zhang L; Yu L
    Medicine (Baltimore); 2024 May; 103(20):e38078. PubMed ID: 38758914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of the microbiota in inflammation, carcinogenesis, and cancer therapy.
    Dzutsev A; Goldszmid RS; Viaud S; Zitvogel L; Trinchieri G
    Eur J Immunol; 2015 Jan; 45(1):17-31. PubMed ID: 25328099
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Influence of the microbiome on the innate immune microenvironment of solid tumors.
    Charles A; Thomas RM
    Neoplasia; 2023 Mar; 37():100878. PubMed ID: 36696837
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Innate lymphoid cells: A potential link between microbiota and immune responses against cancer.
    Panda SK; Colonna M
    Semin Immunol; 2019 Feb; 41():101271. PubMed ID: 30902413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Harnessing the Microbiome to Enhance Cancer Immunotherapy.
    Nelson MH; Diven MA; Huff LW; Paulos CM
    J Immunol Res; 2015; 2015():368736. PubMed ID: 26101781
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microbiota-myeloid cell crosstalk beyond the gut.
    Gorjifard S; Goldszmid RS
    J Leukoc Biol; 2016 Nov; 100(5):865-879. PubMed ID: 27605211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intratumoral microbiota: new frontiers in tumor immunity.
    Zhang Z; Liao Y; Tang D
    Carcinogenesis; 2022 Sep; 43(8):719-727. PubMed ID: 35868230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Innate immune signaling and regulation in cancer immunotherapy.
    Corrales L; Matson V; Flood B; Spranger S; Gajewski TF
    Cell Res; 2017 Jan; 27(1):96-108. PubMed ID: 27981969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Impact of Intratumoral and Gastrointestinal Microbiota on Systemic Cancer Therapy.
    Cogdill AP; Gaudreau PO; Arora R; Gopalakrishnan V; Wargo JA
    Trends Immunol; 2018 Nov; 39(11):900-920. PubMed ID: 30392721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The lung microbiota: role in maintaining pulmonary immune homeostasis and its implications in cancer development and therapy.
    Sommariva M; Le Noci V; Bianchi F; Camelliti S; Balsari A; Tagliabue E; Sfondrini L
    Cell Mol Life Sci; 2020 Jul; 77(14):2739-2749. PubMed ID: 31974656
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bugs in the system: bringing the human microbiome to bear in cancer immunotherapy.
    Strouse C; Mangalam A; Zhang J
    Gut Microbes; 2019; 10(2):109-112. PubMed ID: 30183502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early life microbiome influences on development of the mucosal innate immune system.
    Ignacio A; Czyz S; McCoy KD
    Semin Immunol; 2024 May; 73():101885. PubMed ID: 38788491
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immune System Efficiency in Cancer and the Microbiota Influence.
    Barbosa AM; Gomes-Gonçalves A; Castro AG; Torrado E
    Pathobiology; 2021; 88(2):170-186. PubMed ID: 33588418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of gut and intratumoral microbiota on the immune microenvironment and anti-cancer therapy.
    Chen Y; Liu B; Wei Y; Kuang DM
    Pharmacol Res; 2021 Dec; 174():105966. PubMed ID: 34728366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The microbiome and cancer for clinicians.
    Picardo SL; Coburn B; Hansen AR
    Crit Rev Oncol Hematol; 2019 Sep; 141():1-12. PubMed ID: 31202124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineering immune response to regulate cardiovascular disease and cancer.
    Rani D; Kaur S; Shahjahan ; Dey JK; Dey SK
    Adv Protein Chem Struct Biol; 2024; 140():381-417. PubMed ID: 38762276
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The diverse roles of myeloid derived suppressor cells in mucosal immunity.
    Ashkenazi-Preiser H; Mikula I; Baniyash M
    Cell Immunol; 2021 Jul; 365():104361. PubMed ID: 33984533
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammasomes and the microbiota--partners in the preservation of mucosal homeostasis.
    Levy M; Thaiss CA; Katz MN; Suez J; Elinav E
    Semin Immunopathol; 2015 Jan; 37(1):39-46. PubMed ID: 25315349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.